An overview of the feasibility of nanomedicine in pancreatic cancer theranostics
Kyriakos Kokkinogoulis , Aristomenis Kollas , David Simeonidis , Pavlos Papakostas , Kalliopi Platoni , Efstathios P. Efstathopoulos , Mersini Makropoulou
Exploration of Targeted Anti-tumor Therapy ›› 2025, Vol. 6 ›› Issue (1) : 1002326
Pancreatic ductal adenocarcinoma (PDAC) is among the top causes of cancer-induced mortality, frequently diagnosed too late to be treated effectively, due to the poor prognosis and the limited successful therapeutic options. Apart from the conventional treatments, new multimodal therapies have emerged utilizing different scientific fields for the improvement of the survival and quality of patients’ lives. The advancement of nanotechnology leads the way to more personalized medicine and the use of targeted theranostics carriers for deep-seated cancers such as PDAC. New nanotechnology innovations such as specialized photo-sensitizing drug nanocarriers, can effectively improve photodynamic therapy (PDT) of PDAC and enhance phototherapy’s action through surface plasmon resonance phenomenon, as another recently re-emerged non- or minimally invasive possible treatment of such diseases. Despite the scientific advancements, significant hurdles remain and many parameters need to be examined. However, the novel application of nano-biophotonic techniques and the convergence of different science fields offer promise for the treatment of difficult-to-treat diseases, like PDAC.
Nanomedicine / pancreatic cancer / personalized medicine / photothermal effect / photodynamic therapy / plasmonic photothermal therapy
| [1] |
PANCREATIC CANCER STATISTICS [Internet]. London: World Cancer Research Fund; c2025 [cited 2024 Dec 15]. Available from: https://www.wcrf.org/cancer-trends/pancreatic-cancer-statistics/#:~:text=Latest%20pancreatic%20cancer%20data,of%20pancreatic%20cancer%20in%202020 |
| [2] |
gco.iarc.fr [Internet]. Lyon: IARC; c1965-2025 [cited 2024 Dec 15]. Available from: https://gco.iarc.fr/en |
| [3] |
|
| [4] |
Olajubutu O, |
| [5] |
|
| [6] |
|
| [7] |
Caputo D. Hot topics in pancreatic cancer management. World J Gastrointest Surg. 2023; 15: 121-6. |
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
Pancreatic Cancer Treatment [Internet]. The University of Texas MD Anderson Cancer Center; c2025 [cited 2024 Dec 16]. Available from: https://www.mdanderson.org/cancer-types/pancreatic-cancer/pancreatic-cancer-treatment.html |
| [12] |
|
| [13] |
Asadi S, Bianchi L, De Landro M, |
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
Gilbert JW, |
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
nccn.org [Internet]. National Comprehensive Cancer Network; c2025 [cited 2023 Dec 13]. Available from: https://www.nccn.org/patientresources/patient-resources |
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
FDA grants accelerated approval to zenocutuzumab-zbco for non-small cell lung cancer and pancreatic adenocarcinoma [Internet]. U.S. Food and Drug Administration; [cited 2025 Jan 17]. Available from: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-zenocutuzumab-zbco-non-small-cell-lung-cancer-and-pancreatic |
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
| [51] |
|
| [52] |
|
| [53] |
|
| [54] |
Lane LA. Physics in nanomedicine: Phenomena governing the in vivo performance of nanoparticles. Appl Phys Rev. 2020; 7: 011316. |
| [55] |
|
| [56] |
|
| [57] |
|
| [58] |
|
| [59] |
|
| [60] |
|
| [61] |
|
| [62] |
|
| [63] |
|
| [64] |
|
| [65] |
|
| [66] |
|
| [67] |
|
| [68] |
Nanomedicine upscaling for early clinical phases of multimodal cancer therapy [Internet]. European Union; c 1994-2025 [cited 2025 Feb 5]. Available from: https://doi.org/10.3030/685795 |
| [69] |
New nanomedicine therapy joins the fight against pancreatic cancer [Internet]. European Union; c1994-2025 [cited 2025 Jun 3]. Available from: https://cordis.europa.eu/article/id/435743-new-nanomedicine-therapy-joins-the-fight-against-pancreatic-cancer |
| [70] |
|
| [71] |
|
| [72] |
|
| [73] |
|
| [74] |
|
| [75] |
|
| [76] |
Judson I, |
| [77] |
|
| [78] |
|
| [79] |
|
| [80] |
|
| [81] |
|
| [82] |
Namakshenas P, |
| [83] |
|
| [84] |
|
| [85] |
|
| [86] |
|
| [87] |
|
| [88] |
|
| [89] |
|
| [90] |
|
| [91] |
|
| [92] |
|
| [93] |
|
| [94] |
|
| [95] |
|
| [96] |
|
| [97] |
|
| [98] |
|
| [99] |
|
| [100] |
|
| [101] |
Huang X, Jain PK, El-Sayed IH, El-Sayed MA. Gold nanoparticles: interesting optical properties and recent applications in cancer diagnostics and therapy. Nanomedicine (Lond). 2007; 2: 681-93. |
| [102] |
|
| [103] |
|
| [104] |
|
| [105] |
|
| [106] |
|
| [107] |
|
| [108] |
|
| [109] |
|
| [110] |
|
| [111] |
|
| [112] |
|
| [113] |
|
| [114] |
|
| [115] |
|
| [116] |
|
| [117] |
|
| [118] |
|
| [119] |
Spyratou E, Makropoulou M, |
| [120] |
|
| [121] |
Kareliotis G, Kalkou M, Tsigaridas G, Makropoulou M, |
| [122] |
Kareliotis G, Papachristou M, Priftakis D, Datseris I, |
/
| 〈 |
|
〉 |